LA-2-29:RR:NC:2:239 F80635
Mr. Matt Caffrey
JRH Biosciences
13804 W. 107th St.
Lenexa, KS 66215
RE: The tariff classification of Media Grade Long R3 IGF-1 from Australia.
Dear Mr. Caffrey:
In your letter dated December 2, 1999, you requested a tariff classification ruling for Media Grade Long R3 IGF-1 which you have stated is a non-sterile synthetic derivative of the hormone insulin and is a recombinant of naturally occurring insulin.
It is the opinion of this office that this product is not used as a hormone (i.e., to inhibit or stimulate the functioning of particular organs). Rather, it is used in vitro as a growth stimulant in tissue culture.
The applicable subheading will be 2933.90.7900, Harmonized Tariff Schedule of the United States (HTS), which provides for other aromatic heterocyclic compounds with nitrogen hetero-atom(s) only: products described in additional U.S. note 3 to section VI. The rate of duty will be 9.3 percent ad valorem.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Andrew Stone at (212) 637-7063.
Sincerely,
Robert B. Swierupski
Director,
National Commodity
Specialist Division